BIOGEN INC. — Director's Dealing 2023

Sep 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SANGAMO THERAPEUTICS, INC (SGMO)
CIK: 0001001233
Period of Report: 2023-09-26

Reporting Person: BIOGEN INC. (10% Owner)
Reporting Person: Biogen MA Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-26	Common Stock	S	6000000	$0.50	Disposed	17652466	Indirect

Footnotes

F1: Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.